Seagen, LAVA Therapeutics Ink Worldwide License Agreement To Develop And Commercialize LAVA-1223

RTTNews | Pred 1050 dňami
Seagen, LAVA Therapeutics Ink Worldwide License Agreement To Develop And Commercialize LAVA-1223

(RTTNews) - Seagen Inc. (SGEN), a pioneer in antibody-drug conjugate (ADC) therapies, and LAVA Therapeutics N.V. (LVTX), a clinical-stage immuno-oncology company, announced Monday an exclusive license agreement in which Seagen will work to develop, manufacture and commercialize LAVA-1223.

LAVA-1223 is an advanced preclinical asset that utilizes LAVA's proprietary Gammabody technology to target epidermal growth factor receptor (EGFR)-expressing solid tumors.

Under the terms of the agreement, Seagen will receive an exclusive global license for LAVA-1223 and pay LAVA $50 million upfront; up to approximately $650 million in potential development, regulatory and commercial milestones; and royalties ranging from the single digits to the mid-teens on future sales.

The agreement also provides Seagen with the opportunity to exclusively negotiate rights to apply LAVA's proprietary Gammabody platform on up to two additional tumor targets.

For More Such Health News, visit rttnews.com

read more
Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.
RTTNews | Pred 606 dňami
Seagen Appoints David Epstein As New CEO

Seagen Appoints David Epstein As New CEO

Biotechnology company Seagen Inc. (SGEN) announced Thursday that its Board of Directors has appointed David Epstein as Chief Executive Officer (CEO) and a member of the Board of Directors.
RTTNews | Pred 1005 dňami
Taiwan Shares May Run Out Of Steam On Tuesday

Taiwan Shares May Run Out Of Steam On Tuesday

The Taiwan stock market has moved higher in three straight sessions, rallying more than 685 points or 2.9 percent along the way. The Taiwan Stock Exchange now sits just above the 24,135-point plateau although it may be stuck in neutral on Tuesday. The global forecast for the Asian markets is soft ahead of key U.S. inflation data. The European markets were mixed and the U.S. bourses were down and the Asian markets also figure to track into the red.
RTTNews | Pred 30 minútami
Singapore Q2 GDP Climbs 4.4% On Year

Singapore Q2 GDP Climbs 4.4% On Year

Singapore's gross domestic product expanded 4.4 percent on year in the second quarter of 2025, the Ministry of Trade and Industry said on Tuesday - beating forecasts for 4.3 percent, which would have been unchanged.
RTTNews | Pred 37 minútami
Singapore Bourse May Give Up Support At 4,200 Points

Singapore Bourse May Give Up Support At 4,200 Points

The Singapore stock market has finished lower in two straight sessions, slipping more than 25 points or 0.6 percent along the way. The Straits Times Index now sits just above the 4,230-point plateau and it may extend its losses on Tuesday. The global forecast for the Asian markets is soft ahead of key U.S. inflation data. The European markets were mixed and the U.S. bourses were down and the Asian markets also figure to track into the red.
RTTNews | Pred 1 h 0 min